Lewes, DE -- (SBWIRE) -- 10/02/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Geron Corporation (NASDAQ:GERN), MannKind Corporation (NASDAQ:MNKD), Generex Biotechnology Corporation (OTCMKTS:GNBT), Hudson City Bancorp, Inc. (NASDAQ:HCBK).
Geron Corporation (NASDAQ:GERN), decreased -0.90% and closed at $3.32 on a traded volume of 3.38 million shares, in comparison to 1.73 million shares of average trading volume. So far this year, the stock is up over 135.46%.
The company has a total market capitalization of $427.12 million and its total outstanding shares are 128.65 million.
Has GERN Found The Bottom and Ready To Move Up? Find Out Here
Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California.
MannKind Corporation (NASDAQ:MNKD), plunged -0.51% and closed at $5.67 on a traded volume of 3.33 million shares, whereas its average trading volume is 6.11million shares. In the last three months, the stock is down -16.49%. The Intra-day range for the stock is $5.64 and $5.84.
Will MNKD Get Buyers Even After The Recent Rally? Find Out Here
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States.
Generex Biotechnology Corporation (OTCMKTS:GNBT), dropped down -3.17% and closed at $0.0305. So far in three months, the stock is down -12.86%. The 52-week range for the stock is $0.02 and $0.07 and during the previous trading session it marked$0.03 as its highest price. The stock initially exchanged hands with a price of $0.03 and the overall traded volume that day was 3.31 million shares.
Has GNBT Found The Bottom And Ready To Gain Momentum? Find Out Here
Generex Biotechnology Corporation, a development stage company, engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Hudson City Bancorp, Inc. (NASDAQ:HCBK) after opening its shares at the price of $9.06, jumped up1.43% to close the day at $9.17. The stock ended on a traded volume of 3.24 million shares, in comparison to 3.46 million shares of average trading volume. The 52-week range for the stock is $7.67 and $9.79 and during the previous trading session the stock scored the highest price of $9.17. It started the day at $9.06.
Why Should Investors Buy HCBK After The Recent Gain? Just Go Here and Find Out.
Hudson City Bancorp, Inc. operates as the holding company of Hudson City Savings Bank that provides various banking products and services in the United States.
About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/